Lumos Pharma, Inc. (LUMO)
NASDAQ: LUMO · IEX Real-Time Price · USD
1.540
-0.010 (-0.65%)
At close: Jul 16, 2024, 4:00 PM
1.550
+0.010 (0.65%)
After-hours: Jul 16, 2024, 4:00 PM EDT

Lumos Pharma Revenue

Lumos Pharma had revenue of $1.53M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $165.00K. In the year 2023, Lumos Pharma had annual revenue of $2.05M with 34.67% growth.

Revenue (ttm)
$1.53M
Revenue Growth
-27.48%
P/S Ratio
8.20
Revenue / Employee
$46,212
Employees
33
Market Cap
12.50M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.05M528.00K34.67%
Dec 31, 20221.52M1.29M562.17%
Dec 31, 2021230.00K62.00K36.90%
Dec 31, 2020168.00K--
Dec 31, 20190--
Dec 31, 201812.47M-16.24M-56.55%
Dec 31, 201728.71M-7.06M-19.73%
Dec 31, 201635.77M-32.73M-47.78%
Dec 31, 201568.50M-104.09M-60.31%
Dec 31, 2014172.59M171.50M15,690.67%
Dec 31, 20131.09M-594.00K-35.21%
Dec 31, 20121.69M-185.00K-9.88%
Dec 31, 20111.87M-207.00K-9.96%
Dec 31, 20102.08M1.15M122.59%
Dec 31, 2009934.00K301.00K47.55%
Dec 31, 2008633.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.